Anticancer activity of Yashada Bhasma (bioactive nanoparticles of zinc): A human pancreatic cancer cell line study

BACKGROUND: Pancreatic ductal adenocarcinoma is the fourth leading cause of cancer-related mortality. Efforts to improve cancer treatment through nanotechnology are at the developmental stage, and it will be gracious if the drug with anticancer property itself is a nanoparticle. Bhasma is organomine...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandran, Seetha, Patgiri, Biswajyoti, Bedarkar, Prashant, Mathat, Dinesan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Pharmacological Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891994/
https://www.ncbi.nlm.nih.gov/pubmed/31831971
http://dx.doi.org/10.4103/ayu.AYU_239_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6891994/
https://www.ncbi.nlm.nih.gov/pubmed/31831971
http://dx.doi.org/10.4103/ayu.AYU_239_17

Ejemplares similares